0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Albumin Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17T14618
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Human Albumin Injection Market Research Report 2023
BUY CHAPTERS

Global Human Albumin Injection Market Research Report 2025

Code: QYRE-Auto-17T14618
Report
May 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Albumin Injection Market Size

The global market for Human Albumin Injection was valued at US$ 428 million in the year 2024 and is projected to reach a revised size of US$ 600 million by 2031, growing at a CAGR of 5.0% during the forecast period.

Human Albumin Injection Market

Human Albumin Injection Market

Human albumin solutions are used in a range of medical and surgical problems.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Albumin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Albumin Injection.
The Human Albumin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Albumin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Albumin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Albumin Injection Market Report

Report Metric Details
Report Name Human Albumin Injection Market
Accounted market size in year US$ 428 million
Forecasted market size in 2031 US$ 600 million
CAGR 5.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Blood Extraction
  • Recombine
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Octapharma, CSL Behring, Biotest (UK) Ltd, Baxter, Kedrion Biopharma, Inc., Grifols, GE HealthCare, Bio Products Laboratory, Green Cross, SK Plasma, Instituto Grifols, Takeda, Hualan Bio, Nanyue Biopharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Albumin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Albumin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Human Albumin Injection Market growing?

Ans: The Human Albumin Injection Market witnessing a CAGR of 5.0% during the forecast period 2025-2031.

What is the Human Albumin Injection Market size in 2031?

Ans: The Human Albumin Injection Market size in 2031 will be US$ 600 million.

Who are the main players in the Human Albumin Injection Market report?

Ans: The main players in the Human Albumin Injection Market are Octapharma, CSL Behring, Biotest (UK) Ltd, Baxter, Kedrion Biopharma, Inc., Grifols, GE HealthCare, Bio Products Laboratory, Green Cross, SK Plasma, Instituto Grifols, Takeda, Hualan Bio, Nanyue Biopharmaceuticals

What are the Application segmentation covered in the Human Albumin Injection Market report?

Ans: The Applications covered in the Human Albumin Injection Market report are Hospital, Clinic

What are the Type segmentation covered in the Human Albumin Injection Market report?

Ans: The Types covered in the Human Albumin Injection Market report are Blood Extraction, Recombine

Recommended Reports

Injection Delivery Systems

Human Blood Products

Medical Analysis Devices

1 Human Albumin Injection Market Overview
1.1 Product Definition
1.2 Human Albumin Injection by Type
1.2.1 Global Human Albumin Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Blood Extraction
1.2.3 Recombine
1.3 Human Albumin Injection by Application
1.3.1 Global Human Albumin Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Human Albumin Injection Market Size Estimates and Forecasts
1.4.1 Global Human Albumin Injection Revenue 2020-2031
1.4.2 Global Human Albumin Injection Sales 2020-2031
1.4.3 Global Human Albumin Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Albumin Injection Market Competition by Manufacturers
2.1 Global Human Albumin Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Albumin Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Albumin Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Albumin Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Albumin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Albumin Injection, Product Type & Application
2.7 Global Key Manufacturers of Human Albumin Injection, Date of Enter into This Industry
2.8 Global Human Albumin Injection Market Competitive Situation and Trends
2.8.1 Global Human Albumin Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Albumin Injection Players Market Share by Revenue
2.8.3 Global Human Albumin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Albumin Injection Market Scenario by Region
3.1 Global Human Albumin Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Albumin Injection Sales by Region: 2020-2031
3.2.1 Global Human Albumin Injection Sales by Region: 2020-2025
3.2.2 Global Human Albumin Injection Sales by Region: 2026-2031
3.3 Global Human Albumin Injection Revenue by Region: 2020-2031
3.3.1 Global Human Albumin Injection Revenue by Region: 2020-2025
3.3.2 Global Human Albumin Injection Revenue by Region: 2026-2031
3.4 North America Human Albumin Injection Market Facts & Figures by Country
3.4.1 North America Human Albumin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Albumin Injection Sales by Country (2020-2031)
3.4.3 North America Human Albumin Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Albumin Injection Market Facts & Figures by Country
3.5.1 Europe Human Albumin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Albumin Injection Sales by Country (2020-2031)
3.5.3 Europe Human Albumin Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Albumin Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Human Albumin Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Albumin Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Albumin Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Albumin Injection Market Facts & Figures by Country
3.7.1 Latin America Human Albumin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Albumin Injection Sales by Country (2020-2031)
3.7.3 Latin America Human Albumin Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Albumin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Albumin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Albumin Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Albumin Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Albumin Injection Sales by Type (2020-2031)
4.1.1 Global Human Albumin Injection Sales by Type (2020-2025)
4.1.2 Global Human Albumin Injection Sales by Type (2026-2031)
4.1.3 Global Human Albumin Injection Sales Market Share by Type (2020-2031)
4.2 Global Human Albumin Injection Revenue by Type (2020-2031)
4.2.1 Global Human Albumin Injection Revenue by Type (2020-2025)
4.2.2 Global Human Albumin Injection Revenue by Type (2026-2031)
4.2.3 Global Human Albumin Injection Revenue Market Share by Type (2020-2031)
4.3 Global Human Albumin Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Albumin Injection Sales by Application (2020-2031)
5.1.1 Global Human Albumin Injection Sales by Application (2020-2025)
5.1.2 Global Human Albumin Injection Sales by Application (2026-2031)
5.1.3 Global Human Albumin Injection Sales Market Share by Application (2020-2031)
5.2 Global Human Albumin Injection Revenue by Application (2020-2031)
5.2.1 Global Human Albumin Injection Revenue by Application (2020-2025)
5.2.2 Global Human Albumin Injection Revenue by Application (2026-2031)
5.2.3 Global Human Albumin Injection Revenue Market Share by Application (2020-2031)
5.3 Global Human Albumin Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Octapharma
6.1.1 Octapharma Company Information
6.1.2 Octapharma Description and Business Overview
6.1.3 Octapharma Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Octapharma Human Albumin Injection Product Portfolio
6.1.5 Octapharma Recent Developments/Updates
6.2 CSL Behring
6.2.1 CSL Behring Company Information
6.2.2 CSL Behring Description and Business Overview
6.2.3 CSL Behring Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 CSL Behring Human Albumin Injection Product Portfolio
6.2.5 CSL Behring Recent Developments/Updates
6.3 Biotest (UK) Ltd
6.3.1 Biotest (UK) Ltd Company Information
6.3.2 Biotest (UK) Ltd Description and Business Overview
6.3.3 Biotest (UK) Ltd Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biotest (UK) Ltd Human Albumin Injection Product Portfolio
6.3.5 Biotest (UK) Ltd Recent Developments/Updates
6.4 Baxter
6.4.1 Baxter Company Information
6.4.2 Baxter Description and Business Overview
6.4.3 Baxter Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Baxter Human Albumin Injection Product Portfolio
6.4.5 Baxter Recent Developments/Updates
6.5 Kedrion Biopharma, Inc.
6.5.1 Kedrion Biopharma, Inc. Company Information
6.5.2 Kedrion Biopharma, Inc. Description and Business Overview
6.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolio
6.5.5 Kedrion Biopharma, Inc. Recent Developments/Updates
6.6 Grifols
6.6.1 Grifols Company Information
6.6.2 Grifols Description and Business Overview
6.6.3 Grifols Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Grifols Human Albumin Injection Product Portfolio
6.6.5 Grifols Recent Developments/Updates
6.7 GE HealthCare
6.7.1 GE HealthCare Company Information
6.7.2 GE HealthCare Description and Business Overview
6.7.3 GE HealthCare Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GE HealthCare Human Albumin Injection Product Portfolio
6.7.5 GE HealthCare Recent Developments/Updates
6.8 Bio Products Laboratory
6.8.1 Bio Products Laboratory Company Information
6.8.2 Bio Products Laboratory Description and Business Overview
6.8.3 Bio Products Laboratory Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bio Products Laboratory Human Albumin Injection Product Portfolio
6.8.5 Bio Products Laboratory Recent Developments/Updates
6.9 Green Cross
6.9.1 Green Cross Company Information
6.9.2 Green Cross Description and Business Overview
6.9.3 Green Cross Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Green Cross Human Albumin Injection Product Portfolio
6.9.5 Green Cross Recent Developments/Updates
6.10 SK Plasma
6.10.1 SK Plasma Company Information
6.10.2 SK Plasma Description and Business Overview
6.10.3 SK Plasma Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 SK Plasma Human Albumin Injection Product Portfolio
6.10.5 SK Plasma Recent Developments/Updates
6.11 Instituto Grifols
6.11.1 Instituto Grifols Company Information
6.11.2 Instituto Grifols Description and Business Overview
6.11.3 Instituto Grifols Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Instituto Grifols Human Albumin Injection Product Portfolio
6.11.5 Instituto Grifols Recent Developments/Updates
6.12 Takeda
6.12.1 Takeda Company Information
6.12.2 Takeda Description and Business Overview
6.12.3 Takeda Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Takeda Human Albumin Injection Product Portfolio
6.12.5 Takeda Recent Developments/Updates
6.13 Hualan Bio
6.13.1 Hualan Bio Company Information
6.13.2 Hualan Bio Description and Business Overview
6.13.3 Hualan Bio Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Hualan Bio Human Albumin Injection Product Portfolio
6.13.5 Hualan Bio Recent Developments/Updates
6.14 Nanyue Biopharmaceuticals
6.14.1 Nanyue Biopharmaceuticals Company Information
6.14.2 Nanyue Biopharmaceuticals Description and Business Overview
6.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolio
6.14.5 Nanyue Biopharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Albumin Injection Industry Chain Analysis
7.2 Human Albumin Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Albumin Injection Production Mode & Process Analysis
7.4 Human Albumin Injection Sales and Marketing
7.4.1 Human Albumin Injection Sales Channels
7.4.2 Human Albumin Injection Distributors
7.5 Human Albumin Injection Customer Analysis
8 Human Albumin Injection Market Dynamics
8.1 Human Albumin Injection Industry Trends
8.2 Human Albumin Injection Market Drivers
8.3 Human Albumin Injection Market Challenges
8.4 Human Albumin Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Human Albumin Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Albumin Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Albumin Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Albumin Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Human Albumin Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Albumin Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Albumin Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Albumin Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Albumin Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Albumin Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Albumin Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Human Albumin Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Albumin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Albumin Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Albumin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Albumin Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Human Albumin Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Human Albumin Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Human Albumin Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Human Albumin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Albumin Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Albumin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Albumin Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Albumin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Albumin Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Human Albumin Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Human Albumin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Albumin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Albumin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Albumin Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Human Albumin Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Human Albumin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Albumin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Albumin Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Albumin Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Human Albumin Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Human Albumin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Albumin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Albumin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Albumin Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Human Albumin Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Human Albumin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Albumin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Albumin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Albumin Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Human Albumin Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Human Albumin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Albumin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Albumin Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Human Albumin Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Human Albumin Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Human Albumin Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Human Albumin Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Albumin Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Albumin Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Albumin Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Albumin Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Human Albumin Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Human Albumin Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Human Albumin Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Human Albumin Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Human Albumin Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Human Albumin Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Albumin Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Albumin Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Albumin Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Albumin Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Human Albumin Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. Octapharma Company Information
 Table 71. Octapharma Description and Business Overview
 Table 72. Octapharma Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Octapharma Human Albumin Injection Product
 Table 74. Octapharma Recent Developments/Updates
 Table 75. CSL Behring Company Information
 Table 76. CSL Behring Description and Business Overview
 Table 77. CSL Behring Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. CSL Behring Human Albumin Injection Product
 Table 79. CSL Behring Recent Developments/Updates
 Table 80. Biotest (UK) Ltd Company Information
 Table 81. Biotest (UK) Ltd Description and Business Overview
 Table 82. Biotest (UK) Ltd Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Biotest (UK) Ltd Human Albumin Injection Product
 Table 84. Biotest (UK) Ltd Recent Developments/Updates
 Table 85. Baxter Company Information
 Table 86. Baxter Description and Business Overview
 Table 87. Baxter Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Baxter Human Albumin Injection Product
 Table 89. Baxter Recent Developments/Updates
 Table 90. Kedrion Biopharma, Inc. Company Information
 Table 91. Kedrion Biopharma, Inc. Description and Business Overview
 Table 92. Kedrion Biopharma, Inc. Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Kedrion Biopharma, Inc. Human Albumin Injection Product
 Table 94. Kedrion Biopharma, Inc. Recent Developments/Updates
 Table 95. Grifols Company Information
 Table 96. Grifols Description and Business Overview
 Table 97. Grifols Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Grifols Human Albumin Injection Product
 Table 99. Grifols Recent Developments/Updates
 Table 100. GE HealthCare Company Information
 Table 101. GE HealthCare Description and Business Overview
 Table 102. GE HealthCare Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. GE HealthCare Human Albumin Injection Product
 Table 104. GE HealthCare Recent Developments/Updates
 Table 105. Bio Products Laboratory Company Information
 Table 106. Bio Products Laboratory Description and Business Overview
 Table 107. Bio Products Laboratory Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Bio Products Laboratory Human Albumin Injection Product
 Table 109. Bio Products Laboratory Recent Developments/Updates
 Table 110. Green Cross Company Information
 Table 111. Green Cross Description and Business Overview
 Table 112. Green Cross Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Green Cross Human Albumin Injection Product
 Table 114. Green Cross Recent Developments/Updates
 Table 115. SK Plasma Company Information
 Table 116. SK Plasma Description and Business Overview
 Table 117. SK Plasma Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. SK Plasma Human Albumin Injection Product
 Table 119. SK Plasma Recent Developments/Updates
 Table 120. Instituto Grifols Company Information
 Table 121. Instituto Grifols Description and Business Overview
 Table 122. Instituto Grifols Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Instituto Grifols Human Albumin Injection Product
 Table 124. Instituto Grifols Recent Developments/Updates
 Table 125. Takeda Company Information
 Table 126. Takeda Description and Business Overview
 Table 127. Takeda Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Takeda Human Albumin Injection Product
 Table 129. Takeda Recent Developments/Updates
 Table 130. Hualan Bio Company Information
 Table 131. Hualan Bio Description and Business Overview
 Table 132. Hualan Bio Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Hualan Bio Human Albumin Injection Product
 Table 134. Hualan Bio Recent Developments/Updates
 Table 135. Nanyue Biopharmaceuticals Company Information
 Table 136. Nanyue Biopharmaceuticals Description and Business Overview
 Table 137. Nanyue Biopharmaceuticals Human Albumin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Nanyue Biopharmaceuticals Human Albumin Injection Product
 Table 139. Nanyue Biopharmaceuticals Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Human Albumin Injection Distributors List
 Table 143. Human Albumin Injection Customers List
 Table 144. Human Albumin Injection Market Trends
 Table 145. Human Albumin Injection Market Drivers
 Table 146. Human Albumin Injection Market Challenges
 Table 147. Human Albumin Injection Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Albumin Injection
 Figure 2. Global Human Albumin Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Albumin Injection Market Share by Type: 2024 & 2031
 Figure 4. Blood Extraction Product Picture
 Figure 5. Recombine Product Picture
 Figure 6. Global Human Albumin Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Human Albumin Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Global Human Albumin Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Human Albumin Injection Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Human Albumin Injection Sales (2020-2031) & (K Units)
 Figure 13. Global Human Albumin Injection Average Price (US$/Unit) & (2020-2031)
 Figure 14. Human Albumin Injection Report Years Considered
 Figure 15. Human Albumin Injection Sales Share by Manufacturers in 2024
 Figure 16. Global Human Albumin Injection Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Human Albumin Injection Players: Market Share by Revenue in Human Albumin Injection in 2024
 Figure 18. Human Albumin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Human Albumin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Human Albumin Injection Sales Market Share by Country (2020-2031)
 Figure 21. North America Human Albumin Injection Revenue Market Share by Country (2020-2031)
 Figure 22. United States Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Human Albumin Injection Sales Market Share by Country (2020-2031)
 Figure 25. Europe Human Albumin Injection Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Human Albumin Injection Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Human Albumin Injection Revenue Market Share by Region (2020-2031)
 Figure 33. China Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Human Albumin Injection Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Human Albumin Injection Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Human Albumin Injection Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Human Albumin Injection Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Human Albumin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Human Albumin Injection by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Human Albumin Injection by Type (2020-2031)
 Figure 52. Global Human Albumin Injection Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Human Albumin Injection by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Human Albumin Injection by Application (2020-2031)
 Figure 55. Global Human Albumin Injection Price (US$/Unit) by Application (2020-2031)
 Figure 56. Human Albumin Injection Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS